drugset / Trial / NCT01148368
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
Phase 1
Completed
16 enrolled
Boryung Pharmaceutical Co., Ltd
Seoul National University Hospital · collab
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and the safety of fimasartan in renal impairment patients and healthy volunteers.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fimasartan | Small molecule | 120 mg | — |